<html>
<head>
    <meta name="GENERATOR" content="Microsoft Visual Studio 6.0">
    <title>Biological Use Authorization</title>
    <!-- <link rel="stylesheet" type="text/css" href="/appAsp/Include/ORA1.css"> -->
    <!-- <link rel="stylesheet" type="text/css" href="/appAsp/Include/Ora_BlueTables.css"> -->
    <link rel="stylesheet" type="text/css" href="/OrPortal/Forms/Compliance/IBC/IBC.css">
    <!-- Get Database Subroutines -->
    
    <!-- End Get Database Subroutines -->
    <!-- #XXXinclude virtual = "/appAsp/Include/StringUtilities.asp" -->
    
    <style>
.OriginalValuesBorder {
    border:3px solid orange;margin-top:5px;
}
.OriginalValuesTitle {
    color:orange;
    font-weight:bold;
}
.highlight {
    background-color:lightyellow; 
    border:1px solid orange;
    padding:2px;
}
.SemiHighlight {
    color:orange;
}
.warning {
    background-color:#FFE4C4; 
    border:1px solid orange;
    padding:2px;
}

th, .thBlue	{
	text-align:left;
	vertical-align:top;
	font-size:8pt;
	font-weight:bold;
	font-family:verdana;
}
td, .tdBlue	{
	text-align:left;
	vertical-align:top;
	font-size:8pt;
	font-family:verdana;
}

.THLine1 {
	color:navy;
	background:#F5F5F5;
	font-size:8pt;
	font-weight:bold;
}
.TDLine1 {
	color:navy;
	background:#F5F5F5;
	font-size:8pt;
}

.THLine2 {
	color:navy;
	background:white;
	font-size:8pt;
	font-weight:bold;
}
.TDLine2 {
	color:navy;
	background:white
	font-size:8pt;
}


.GlobalTd {
	background:white;
	color:navy;
	font-size:9pt;
}
.hdg1 {
	background:white;
	color:navy;
	font-size:12pt;
	font-weight:bold;
}
.xxxhdg2 {
	background:white;
	color:brown;
	font-size:11pt;
	font-weight:bold;
}
.hdg2 {
	background:navy;
	color:white;
	font-size:11pt;
	font-weight:bold;
	margin:1px;
	border-width:1px;
	border-color:white;
	padding:2px;
}
.hdg3 {
	background:white;
	color:navy;
	font-size:12pt;
	font-weight:bold;
}


</style>
    <script>window.status='ORA Production Database';</script>
</head>
<body>
    <form action method="POST" id="form1" name="form1">
        <!-- Outer Table -->
        <table width="650" cellpadding="2" cellspacting="0" border="1">
            <tr>
                <td class="GlobalTd">
                    <script>window.status='ORA Production Database';</script><table width="100%" cellpadding="0" cellspacing="0" border="0px"><tr>
<td>Protocol#: B-20180053-01 (Amendment)</td>
<td style="text-align:right;">
<input type="checkbox" name="Compare">Compare with Original&#160;<input type="submit" name="Refresh" value="Go">
</td>
</tr></table>
<br><br><div class="hdg1" align="center">University of California, Riverside<br>Institutional Biosafety Committee (IBC)<br>Application for Biological Use Authorization Registration</div>
<br><div class="hdg2">A. INVESTIGATOR DATA</div>
<table border="0" cellpadding="1" cellspacing="1" width="100%">
<tr>   <th class="THBlue">Principal Investigator</th>   <td class="TDBlue">Meera  Nair</td>
<td rowspan="10">&#160;&#160;&#160;&#160;&#160;</td>   <th class="THBlue">Email</th>   <td class="TDBlue">meeran@ucr.edu</td>
</tr>
<tr>   <th class="THBlue">Department</th>   <td class="TDBlue">Biomedical Sciences</td>   <th class="THBlue">Phone</th>   <td class="TDBlue">(951) 827-7734</td>
</tr>
<tr>   <th class="THBlue">Project Start/End Date</th>   <td class="TDBlue">2/16/2012-11/16/2022</td>   <th class="THBlue">Fax</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue" colspan="5">
<br>Project Title:</th>
</tr>
<tr>   <td class="TDBlue" colspan="5">Mucosal models of inflammation</td>
</tr>
<tr>   <th class="THBlue" colspan="5">
<br>Related Funding Agency(ies) (add as many as apply, even if use of rDNA is identical for each project):</th>
</tr>
<tr>   <td class="TDBlue" colspan="5">Intramural
NIH</td>
</tr>
<tr><td colspan="5">&#160;</td></tr>
<tr>   <th class="THBlue" colspan="2">Additional Contact person and phone # (if not or in addition to the PI):</th>   <td class="TDBlue" colspan="2"></td>
</tr>
</table>
<br><br><div class="hdg2">B. RESEARCH LOCATIONS</div>
<table border="1" width="100%" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue" width="15%">Building &#160;&#160;&#160;</th>   <th class="THBlue" width="15%">Room #  &#160;&#160;&#160;</th>   <th class="THBlue" width="55%">List any containment facilities or equipment (biosafety cabinets, etc.) and their last certification dates. &#160;&#160;&#160;</th>   <th class="THBlue" width="15%">Certification<br>Date</th>
</tr>
<tr>   <td class="TDBlue">Spieth Vivarium&#160;&#160;&#160;</td>   <td class="TDBlue">359a&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Keen Hall&#160;&#160;&#160;</td>   <td class="TDBlue">1005-1018; 2003-2023&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Webber&#160;&#160;&#160;</td>   <td class="TDBlue">1235,1252,1254,2140,2101&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">LSP&#160;&#160;&#160;</td>   <td class="TDBlue">418, 434, 438&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">SOM Research Building&#160;&#160;&#160;</td>   <td class="TDBlue">241,233,330,341&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Psychology vivarium &#160;&#160;&#160;</td>   <td class="TDBlue">1408,1414,1406,1416,1421,1422 &#160;&#160;&#160;</td>   <td class="TDBlue">Biosafety cabinet in 1408 and 1421. Zika virus will only be handled in the biosafety cabinet in 1406 (BSL2 procedure room) and Zika infected mice will be housed in the BSL2 vivarium room (1408). For Zika virus infected mice, mice will be dissected in the vivarium and only tissue transported to the lab   &#160;&#160;&#160;</td>   <td class="TDBlue">6/5/2018&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">SOM Research building&#160;&#160;&#160;</td>   <td class="TDBlue">332   &#160;&#160;&#160;</td>   <td class="TDBlue">2 biosafety cabinets. This will be the only location in the SOM Research building where live Zika virus will be handled.   &#160;&#160;&#160;</td>   <td class="TDBlue">4/24/2018&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">MRB&#160;&#160;&#160;</td>   <td class="TDBlue">3223,3205A/E, 3rd fl benches&#160;&#160;&#160;</td>   <td class="TDBlue">Biosafety cabinets in 3205A moved from SOMRB 332&#160;&#160;&#160;</td>   <td class="TDBlue">4/24/2018&#160;&#160;&#160;</td>
</tr>
</table>
<br><br><div class="hdg2">C. PRIOR APPROVAL STATUS</div>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th width="50%" class="THBlue">Application Type</th>   <td width="50%" class="TDBlue">Renewal</td>
</tr>
<tr>   <th class="THBlue">If &#8220;Yes&#8221;, please list the number of the approved protocol</th>   <td class="TDBlue">20160004</td>
</tr>
<tr>   <th class="THBlue">Does this project involve human or animal subjects, or a positive disclosure of a conflict of interest (income, loans, or management role in funding source, etc.)?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;Yes&#8221;, has this project been reviewed by any other UCR review boards?  If so, indicate the relevant protocol numbers and approval dates:</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">IRB (human subjects)</th>   <td class="TDBlue">HS-14-155, HS-13-134, HS 17-107</td>
</tr>
<tr>   <th class="THBlue">IACUC (animal subjects)</th>   <td class="TDBlue">A-20180023</td>
</tr>
<tr>   <th class="THBlue">Conflict of interest (provide approval date)</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Does this project involve strains of plant or animal pathogens not originating in California?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;Yes&#8221;, CDFA and APHIS permits may be required.  List the relevant permit numbers and dates covered:</th>
</tr>
<tr>   <th class="THBlue">CDFA</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">APHIS</th>   <td class="TDBlue">No APHIS permit required - USDA consulted</td>
</tr>
<tr>   <th class="THBlue">Do experiments involve releasing organisms containing rDNA into the environment?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;Yes&#8221;, has an application for this release been filed with a state or federal regulatory agency?	Agency and date filed:</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Will you be using  a "Select Agent" (<a href="http://www.cdc.gov/od/ohs/lrsat.htm">www.cdc.gov/od/ohs/lrsat.htm</a>)</th>   <td class="TDBlue">False</td>
</tr>
</table>
<br><br><div class="hdg2">DESCRIPTION OF PROJECT</div>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th class="THBlue">Provide a brief, non-technical description and purpose of the project.</th>
</tr>
<tr>   <td class="TDBlue">Research in the Nair lab is focused on understanding the function of macrophages recruited to mucosal sites following infection and how they regulate host immunity and inflammation. Specific areas of research include investigating the
function of alternatively activated macrophages in helminth infection-induced lung and gut inflammation. Additionally, the lab employs models of intestinal inflammation including bacterial infection and chemical induced injury to investigate what cell-types and cell-derived factors are important to regulate this response.
An additional avenue of research in collaboration with Dr Rong Hai will be to understand the importance of the host immune response to Influenza and Zika virus infection.
</td>
</tr>
<tr>   <th class="THBlue">What are the specific objectives of the work with biohazardous materials?</th>
</tr>
<tr>   <td class="TDBlue">To understand how the host immune response combats pathogenic infections as well as regulate dangerous inflammatory responses, we employ murine models of infection and injury-induced inflammation. This includes using infectious agents such as helminths (Nippostrongylus, Trichinella, Trichuris, Heligmosomoides), bacteria (Salmonella, Listeria, Citrobacter), parasites (Toxoplasma), and viruses (Zika, Influenza) and chemicals (dextran sodium sulfate).
Zika virus- specific information: Investigating ZKIV replication will enable us to understand the differential replication kinetics of ZIKV in mouse immune cells. This study supplies vital information for further understanding its replication characters. In addition, it supplied an important tool for evaluating efficacy of screening antivirals.
E.coli-induced sepsis. To identify new therapeutics for sepsis, we propose a mouse sepsis model. Mice will be infected with intraperitoneal injection of E. coli (ATCC 25922) at 2-20x107 cfu. The E. coli strain is designated biosafety level 1, and standard CDC guidelines will be followed to ensure other mice are not infected. </td>
</tr>
</table>
<br><br><div class="hdg2">Potentially Biohazadous Materials</div>Please indicate yes or no if the following biohazardous materials are used currently within your laboratory or are proposed with the next year.  Please check all that apply.<table width="100%" border="0" cellpadding="0" cellspacing="0">
<tr>   <th colspan="2"><span class="hdg3">Human or Animal Infectious Agents</span></th>
</tr>
<tr>   <th class="THLine1">Viruses</th>   <td class="TDLine1">True</td>
</tr>
<tr>   <th class="THLine2">Bacteria</th>   <td class="TDLine2">True</td>
</tr>
<tr>   <th class="THLine1">Fungi</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Prions</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">True</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Plant Infectious Agents</span>
</th>
</tr>
<tr>   <th class="THLine1">Viruses</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Bacteria</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Fungi</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Other</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Recombinant DNA</span>
</th>
</tr>
<tr>   <th class="THLine1">Recombinant DNA in any form.</th>   <td class="TDLine1">True</td>
</tr>
<tr>   <th class="THLine2">Intentional release to the environment</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Transgenic Plants</span>
</th>
</tr>
<tr>   <th class="THLine1">Plants</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Liverworts</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Mosses</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Algae</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Animals</span>
</th>
</tr>
<tr>   <th class="THLine1">Animals that are potential reservoirs of zoonotic diseases<br>(primates, wild animals, etc.)</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Infectious or hazardous agents in animals</th>   <td class="TDLine2">True</td>
</tr>
<tr>   <th class="THLine1">Human or primate cells in animals</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Transgenic animals</th>   <td class="TDLine2">True</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Invertebrates</span>
</th>
</tr>
<tr>   <th class="THLine1">Exotic Arthropods</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Nematodes</th>   <td class="TDLine2">True</td>
</tr>
<tr>   <th class="THLine1">Intentional release to the environment</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Transgenic Insects</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Human Stem Cells</span>
</th>
</tr>
<tr>   <th class="THLine1">Human Stem Cells</th>   <td class="TDLine1">False</td>
</tr>
</table>
<br><div class="hdg2">Human or Animal Infectious Agents</div>
<table width="100%" border="1" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue">List of Agents &#160;&#160;&#160;</th>   <th class="THBlue">Host of Range of Agent &#160;&#160;&#160;</th>
</tr>
<tr>   <td class="TDBlue">Nippostrongylus brasiliensis&#160;&#160;&#160;</td>   <td class="TDBlue">mouse,rat&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Citrobacter rodentium&#160;&#160;&#160;</td>   <td class="TDBlue">mouse, rat&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Trichinella spiralis&#160;&#160;&#160;</td>   <td class="TDBlue">mouse, rat, human&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Trichuris muris&#160;&#160;&#160;</td>   <td class="TDBlue">mouse, rat&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Toxoplasma gondii&#160;&#160;&#160;</td>   <td class="TDBlue">mouse, rat, human&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Heligmosomoides polygyrus&#160;&#160;&#160;</td>   <td class="TDBlue">mouse, rat&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Influenza A virus, H1, H3, influenza B virus&#160;&#160;&#160;</td>   <td class="TDBlue">human, mouse&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">ZIKA virus strain H/PF/2013&#160;&#160;&#160;</td>   <td class="TDBlue">human, mouse&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">E.coli (for sepsis model: ATCC 25922, https://www.atcc.org/~/ps/25922.ashx ; for cloning eg. TOP10 competent cells)&#160;&#160;&#160;</td>   <td class="TDBlue">mouse, rat, human&#160;&#160;&#160;</td>
</tr>
</table>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th width="50%" class="THBlue">Are you using the wild-type of the agent?</th>   <td width="50%" class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">Are you using genetically modified infectious agents (rDNA, mutagenesis, etc.)?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; please describe the agent and any potential safety issues.</th>   <td class="TDBlue">Bacterial strains have been modified to be resistant to a single antibiotic.  Other bacterial strains will contain fluorescent indicators or model antigens (e.g. ovalbumin).
</td>
</tr>
<tr>   <th class="THBlue">Do the experiments have the potential to increase the host range of the agent?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Is the vector replication competent?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">Are you using fusion proteins or cell entry domains?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; please describe any safety precautions you would recommend.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Are you using human or primate blood, blood products, cells, cell lines or tissues</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#147;yes,&#148; please describe the blood, blood products, cells, cell lines or tissue and detail how the sample will be worked with during experimentation. Please include vendor information such as the ATCC number if available.</th>   <td class="TDBlue">HEK 293t cells cultures will be used for transfections or activation in vitro. Human samples are used to understand immune regulation in infection and sepsis. Human sera will be used for protein assays. Human peripheral blood cells will be used for in vitro cultures. Handling of these samples will occur in a BSL-2 certified room and hood. For disposal or final analysis outside of BSL2 areas, samples will be killed by 4% paraformaldehyde or soaked in 10% bleach. Human blood cells are obtained commercially (Zenbio) from blood draws from the Riverside free clinic and from the Riverside University Health Systems, as specified in approved IRB. Human blood cells are not fixed during transport, but handled according to BSL2 guidelines - closed, screw top container and secondary container.</td>
</tr>
</table>
<br><div class="hdg2">Recombinant DNA</div>
<table width="100%" border="1" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue">General features of the DNA &#160;&#160;&#160;</th>   <th class="THBlue">Species from which DNA originated &#160;&#160;&#160;</th>   <th class="THBlue">Species to receive DNA, type of vector, and transformation method &#160;&#160;&#160;</th>
</tr>
<tr>   <td class="TDBlue">Genes for resistin-like molecules; genes for fluorescent tags and model antigens (e.g. ovalbumin; non-hazardous proteins used for detection).&#160;&#160;&#160;</td>   <td class="TDBlue">mouse, chicken, jelly-fish, human.&#160;&#160;&#160;</td>   <td class="TDBlue">human cells, mouse cells, hamster cells, rat cells; lipid transfection.&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">commercially available plasmids (e.g.. openbiosystem pCMVsport) with inserted gene of interest (Retnl; Retn)&#160;&#160;&#160;</td>   <td class="TDBlue">Mouse and human&#160;&#160;&#160;</td>   <td class="TDBlue">cultured human cells (HEK293T) or insect cells&#160;&#160;&#160;</td>
</tr>
</table>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th width="50%" class="THBlue">Will cultures of any recombinant organisms listed above exceed a volume of 10 liters?  </th>   <td width="50%" class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If so, where will the cultures be grown?</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Does your experiment involve the transfer of a drug resistance trait to any microorganism, plant, or insect that does not acquire that trait naturally?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe any potential environmental or health hazards of the experiments, including whether acquiring such a trait would compromise the use of the drug in medicine or agriculture.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Are you expressing genes encoding toxins with LD 50 less that 10 ng/kg of body weight?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe the toxic product and safety precautions.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Are you using hosts or vectors of rDNA (excluding E. coli K-12) that are viable pathogens of animals, plants, or microbes?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe any potential environmental or health hazards, containment precautions, and disposal protocols.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Are you using recombinant DNA molecules containing the partial genome of any eukaryotic (plant or animal) virus?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe the molecules, including genetic maps and the fraction of virus genome present, and safety precautions.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Are your experiments likely to enhance the pathogenicity or extend the host range of a viral vector (e.g., introduction of novel control elements or a oncogene)?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe the hazards and safety precautions.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Will you be using genes involved in cell cycle control in animals (oncogene, tumor suppressor, cytokine, etc.)?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe the potential hazards.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Medical surveillance requirements or practices that you would recommend (antibody titering, etc.)?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, list your recommendations in section 5.</th>   <td class="TDBlue"></td>
</tr>
</table>
<br><div class="hdg2">Vertebrates</div>
<table width="100%" border="1" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue">Animal &#160;&#160;&#160;</th>   <th class="THBlue">Infectious Agent &#160;&#160;&#160;</th>   <th class="THBlue">Route(s) of Shedding/Excretion of Infectious Agents &#160;&#160;&#160;</th>
</tr>
<tr>   <td class="TDBlue">mouse, rat&#160;&#160;&#160;</td>   <td class="TDBlue">nippostrongylus brasiliensis, trichinella spiralis, trichuris muris, heligmosomoides polygyrus, citrobacter rodentium&#160;&#160;&#160;</td>   <td class="TDBlue">feces&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">mouse/human&#160;&#160;&#160;</td>   <td class="TDBlue">Zika virus&#160;&#160;&#160;</td>   <td class="TDBlue">blood&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">mouse/human&#160;&#160;&#160;</td>   <td class="TDBlue">Influenza&#160;&#160;&#160;</td>   <td class="TDBlue">Respiratory route&#160;&#160;&#160;</td>
</tr>
</table>
<table border="0" width="100%" cellpadding="7" cellspacing="0">
<tr>   <th width="50%" class="THBlue">Are you using human or primate cells in animals?</th>   <td width="50%" class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Are you infecting animals with infectious agents?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; describe any potential environmental or health hazards, containment precautions, and disposal protocols.</th>   <td class="TDBlue">For helminths and bacterial: transmission of these pathogens are through the oral-fecal route. The risk of spread of the infectious agent will be eliminated with appropriate cage cleaning, wiping the surfaces with bleach, disposing of the carcasses. Additionally, personnel will be required to wear PPE (gloves, lab coat, eye protection)

For Influenza: Animal might bite the researcher. 
Proper PPE gloves will required to handle animals. Influenza virus is a respirotory pathogen. Researchers are required to wear protection mask to work on influenza virus. Researchers are required not to position any container, close to their noses.

For Zika virus: Zika can be transmitted through the blood from needle stick injuries. All workers are required to use proper PPE when handling the virus and infected animals will be handled in biosafety cabinets. Zika can also be transmitted through mosquitoes, however the presence of mosquitoes in the vivarium BSL2 room is highly unlikely. Additionally,</td>
</tr>
<tr>   <th class="THBlue">Do the animals shed the infectious agents?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; how long will shedding of the infectious agent occur?</th>   <td class="TDBlue">For helminth and bacterial infections: the infection is acute, but resolved, with maximal shedding in the feces around days 7-15.

Zika and Influenza are not shed from mice.</td>
</tr>
<tr>   <th class="THBlue">Are you using animals that have been caught in the wild?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Are there potential zoonotic diseases associated with the animals?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; describe any potential environmental or health hazards, containment precautions, and disposal protocols.</th>   <td class="TDBlue"></td>
</tr>
</table>
<br><div class="hdg2">Invertebrates</div>
<table width="100%" border="1" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue">List of Invertebrates &#160;&#160;&#160;</th>   <th class="THBlue">Range of Invertebrates &#160;&#160;&#160;</th>   <th class="THBlue">Exotic &#160;&#160;&#160;</th>
</tr>
<tr>   <td class="TDBlue">nippostrongylus, trichuris&#160;&#160;&#160;</td>   <td class="TDBlue">tropical and subtropical&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">trichinella, heligmosomoides&#160;&#160;&#160;</td>   <td class="TDBlue">tropical and subtropical&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
</table>
<table border="0" width="100%" cellpadding="7" cellspacing="0">
<tr>   <th width="50%" class="THBlue">Is the organism an arthropod?</th>   <td width="50%" class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Does the arthropod belong to one of the following categories: D. melanogaster, Coleoptera, Lepidoptera, cockroaches and was purchased locally or collected from local populations?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Does the arthropod transmit pathogens of public health importance?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; then please list which ones.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Is the arthropod regulated by USDA or USFWS?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; please list any permits.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">If the arthropod escaped would it be inviable or transient?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Is there active vector borne disease cycling?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Is the arthropod itself genetically engineered or does it now contain an engineered virus or endosymbiont.</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Does the arthropod contain an engineered foreign, autonomous transposable element?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Are the mobility properties of the transposable element known?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Can the transposable element spread through the species?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Suggested level of biological containment.</th>   <td class="TDBlue">
<img src="/appAsp/images/CheckedBox.gif">ACL1 &#160;&#160;&#160;<img src="/appAsp/images/CheckBox.gif">ACL2 &#160;&#160;&#160;<img src="/appAsp/images/CheckBox.gif">ACL3 &#160;&#160;&#160;</td>
</tr>
</table>
<br><br><div class="hdg2">Define Controls</div>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th class="THBlue" width="50%">Do you need special equipment, engineering safeguards or personal protective equipment to maintain containment of your experiments (hoods, negative pressure rooms, gloves, etc.) </th>   <td class="TDBlue" width="50%">True</td>
</tr>
<tr>   <th class="THBlue"> If &#8220;yes&#8221;, list your recommendations.</th>   <td class="TDBlue">Biosafety cabinets.
PPE: eye protection, lab coats, gloves.
Containment of agents in closed containers.
Following procedure, wipe surfaces with bleach. Waste will be disinfected in bleach. Contaminated plastics will be autoclaved and disposed of. Glassware will be bleached, washed and autoclaved.

For virus-related work:
1. All the work related to viruses pathogen will be conducted in the hood. 
2. All container for viral pathogen  should be air sealed. 
3. -80 Freezer, which is the main storage for viral pathogen, is required to be locked.
4. No pregnant women are allowed to work with the zika virus or virus-infected tissue and cells that are not fixed with paraformaldehyde.</td>
</tr>
<tr>   <th class="THBlue">Medical surveillance requirements or practices that you would recommend (antibody titering, etc.)? </th>   <td class="TDBlue">Annual influenza vaccine will be recommended.
For ZIKA virus: According to CDC reports (http://www.cdc.gov/zika/hc-providers/testing-for-zikavirus.html), the sensitivity of the assays (molecular quantification of Zika virus, or ELISA for Zika-specific IgM) only permit detection of Zika virus infection in a specific time window: 5-7 days post-exposure or clinical symptoms for molecular diagnostics, and 7-14 days post clinical symptoms for ELISA. Also, if the individual is asymptomatic, it is lik</td>
</tr>
<tr>   <th class="THBlue">Suggested level of biological containment.</th>   <td class="TDBlue">BSL2</td>
</tr>
</table>
<br><div class="hdg2">Acknowledgement of Responsibilities</div>
<div class="tdBlue">For each of the elements below, please indicate if you will be following the UCR standard operating procedures and/or policies. If you indicate &#8220;yes&#8221; then you agree to and must follow the standard procedures and/or policies. If you answer &#8220;no,&#8221; please enter a brief description (in the space provided below the question) of the procedure you will follow and include a justification for deviating from the standard procedure and/or policy.</div>
<table border="0" width="100%" cellpadding="7" cellspacing="0">
<tr>   <th class="THBlue">Decontamination of biohazardous spills: I will used a 0.5 % sodium hypochlorite  (1:10 dilution of household bleach) to decontaminate equipment and work surfaces.  In locations where bleach would cause corrosion, I will decontaminate with an iodophor (e.g., Wescodyne).</th>   <td class="TDBlue" nowrap>True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Storage: Biohazardous material will be clearly labeled with the universal biohazard symbol.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">If I am using human or non-human primate blood or blood products, unfixed tissue, bodily fluids or organ or cell cultures of human origin, I will follow the exposure control plan for bloodborne pathogens.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">All injuries and accidental inoculation, ingestion or inhalation of biohazardous material will be reported immediately to the lab director or supervisor and EH&amp;S (827-2648).  Dial 911 immediately for any medical emergency.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">All shipments of biological materials will follow university policy and all applicable federal and international regulations whenever shipped domestically or internationally.  Proper importation or exportation permits and licenses will be obtained before shipping or reviving biological materials to or from any international location.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">If I am generating medical and/or biohazardous waste, I will abide by the UC Riverside Medical and/or Biological waste plans.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">I understand that UC Riverside may be required by law to release a copy of this application to the public.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">I understand that failure to comply with the applicable regulations governing the use of biohazardous materials described above may result in suspension of the authorization and might jeopardize any funding supporting the activities described herein.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">I attest that I will conduct the study identified above in the manner described.  If I decide to make any changes in the procedure or if any problems occur which involve risk or the possibility of risk to others, I will immediately report such occurances or contemplated changes to the UCR Institutional Biosafety Committee, Research and Economic Development, 200 University Office Building, ext 2-4809; IBC@ucr.edu.</th>   <td class="TDBlue">True</td>
</tr>
</table>
<br><table border="0" width="100%" cellpadding="0" cellspacing="0">
<tr>
<td>______________________________</td>
<td>___________</td>
<td rowspan="2">&#160;&#160;&#160;&#160;</td>
<td>______________________________</td>
<td>___________</td>
</tr>
<tr>
<td>Principal Investigator</td>
<td>Date</td>
<td>Co-Investigator</td>
<td>Date</td>
</tr>
</table>
<br><em>Electronically signed and submitted to ORA on 3/4/2019 3:32:10 PM by <b>Meera Nair</b></em><hr>IBC CERTIFICATION<div class="tdBlue">I certify that the Institutional Biosafety Committee has reviewed the proposed project.  In compliance with NIH guidelines and other specific NIH instructions, the project is (check one)<br><img src="/appAsp/images/CheckedBox.gif"> Approved as is.<br><img src="/appAsp/images/CheckBox.gif"> Approved with the following conditions:<br><br><br>
</div>
<table border="0" width="100%" cellpadding="0" cellspacing="0">
<tr>
<td>Level:	<img src="/appAsp/images/CheckBox.gif">BL1 &#160;&#160;<img src="/appAsp/images/CheckedBox.gif">BL2 &#160;&#160;<img src="/appAsp/images/CheckBox.gif">BL3 &#160;&#160;<img src="/appAsp/images/CheckBox.gif">BL4 &#160;&#160;</td>
<td>
<em>Electronically Signed by<br><u><b>Peter Atkinson</b></u></em> __________________________4/19/2019</td>
</tr>
<tr>
<td>&#160;</td>
<td>Chair-Institutional Biosafety Committee &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Date</td>
</tr>
</table>
                    <!-- End Outer Table -->
                </td>
            </tr>
        </table>
    </form>
</body>
</html>
